Literature DB >> 9351646

Modulation of rat brain cannabinoid receptors after chronic morphine treatment.

T Rubino1, L Tizzoni, D Viganò, P Massi, D Parolaro.   

Abstract

Intraperitoneal injection of delta9-THC (7.5 mg/kg) in rats made tolerant to morphine by s.c. implantation of morphine pellets had a much greater analgesic effect than in placebo pellet plus delta9-THC treatment. To investigate whether this was due to some change in cannabinoid receptor levels and/or expression induced by chronic morphine, we designed this autoradiographic binding study coupled with in situ hybridization on sagittal sections of the treated rat brains. Binding showed a significant increase in CB1 receptor density (15%) specifically in the caudate-putamen, in parallel with a significant enhancement of CB1 mRNA in the same area (20%). We suggest that morphine chronic treatment leads to a functional modulation between the opioid and cannabinoid systems at least for analgesia in a specific area, in this case the striatum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351646     DOI: 10.1097/00001756-199710200-00007

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 2.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

3.  Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.

Authors:  Ahmet Altun; Kemal Yildirim; Ercan Ozdemir; Ihsan Bagcivan; Sinan Gursoy; Nedim Durmus
Journal:  J Physiol Sci       Date:  2015-04-18       Impact factor: 2.781

4.  Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.

Authors:  Daniela Viganò; Tiziana Rubino; Angelo Vaccani; Silvia Bianchessi; Patrick Marmorato; Chiara Castiglioni; Daniela Parolaro
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.

Authors:  M Sabrina Spano; Liana Fattore; Gregorio Cossu; Serena Deiana; Paola Fadda; Walter Fratta
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

6.  The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.

Authors:  Adrianne R Wilson-Poe; Edvinas Pocius; Melissa Herschbach; Michael M Morgan
Journal:  Pharmacol Biochem Behav       Date:  2012-10-10       Impact factor: 3.533

Review 7.  Cannabinoid-opioid interactions during neuropathic pain and analgesia.

Authors:  Ittai Bushlin; Raphael Rozenfeld; Lakshmi A Devi
Journal:  Curr Opin Pharmacol       Date:  2009-10-25       Impact factor: 5.547

Review 8.  Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.

Authors:  Gianluigi Tanda; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

9.  Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.

Authors:  A R Wilson-Poe; B K Lau; C W Vaughan
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

10.  Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.

Authors:  Adrianne R Wilson; Lauren Maher; Michael M Morgan
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.